In vivo differentiated human embryonic stem cells can acquire chromosomal aberrations more frequently than in vitro during the same period

Stem Cells and Development

Volumn 21, Issue 18, 2012, Pages 3363-3371

  Zucchelli, Marco ^a   Ström, Susanne ^a   Holm, Frida ^b   Malmgren, Helena ^b   Sahlén, Sigrid ^b   Religa, Piotr ^b   Hovatta, Outi ^a   Kere, Juha ^a   Inzunza, José ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CHROMOSOME 12; CHROMOSOME 17; CHROMOSOME ABERRATION; CHROMOSOME MUTATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KARYOTYPE 46,XX; KARYOTYPE 46,XY; MALE; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SCID MOUSE; STEM CELL TRANSPLANTATION; X CHROMOSOME;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; DNA COPY NUMBER VARIATIONS; EMBRYONIC STEM CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPE; MUTATION; MUTATION RATE; TERATOMA;

EID: 84870782394     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0066     Document Type: Article

References (29)

1. Thomson JA, J Itskovitz-Eldor, SS Shapiro, MA Waknitz, JJ Swiergiel, VS Marshall and JM Jones. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147.
2. Reubinoff BE, MF Pera, CY Fong, A Trounson and A Bongso. (2000). Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18:399-404.
3. Hovatta O, M Stojkovic, M Nogueira and I Varela-Nieto. (2010). European scientific, ethical, and legal issues on human stem cell research and regenerative medicine. Stem Cells 28:1005-1007.
4. Drukker M and N Benvenisty. (2004). The immunogenicity of human embryonic stem-derived cells. Trends Biotechnol 22:136-141.
5. Grinnemo KH, M Kumagai-Braesch, A Mansson-Broberg, H Skottman, X Hao, A Siddiqui, A Andersson, AM Stromberg, R Lahesmaa, et al. (2006). Human embryonic stem cells are immunogenic in allogeneic and xenogeneic settings. Reprod Biomed Online 13:712-724.
6. Stojkovic M, M Lako, P Stojkovic, R Stewart, S Przyborski, L Armstrong, J Evans, M Herbert, L Hyslop, et al. (2004). Derivation of human embryonic stem cells from day-8 blastocysts recovered after three-step in vitro culture. Stem Cells 22:790-797.
7. Yamanaka S. (2007). Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1:39-49.
8. Baker DE, NJ Harrison, E Maltby, K Smith, HD Moore, PJ Shaw, PR Heath, H Holden and PW Andrews. (2007). Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat Biotechnol 25:207-215.
9. Cowan CA, I Klimanskaya, J McMahon, J Atienza, J Witmyer, JP Zucker, S Wang, CC Morton, AP McMahon, et al. (2004). Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 350:1353-1356.
10. Mitalipova MM, RR Rao, DM Hoyer, JA Johnson, LF Meisner, KL Jones, S Dalton and SL Stice. (2005). Preserving the genetic integrity of human embryonic stem cells. Nat Biotechnol 23:19-20.
11. Maitra A, DE Arking, N Shivapurkar, M Ikeda, V Stastny, K Kassauei, G Sui, DJ Cutler, Y Liu, et al. (2005). Genomic alterations in cultured human embryonic stem cells. Nat Genet 37:1099-1103.
12. Herszfeld D, E Wolvetang, E Langton-Bunker, TL Chung, AA Filipczyk, S Houssami, P Jamshidi, K Koh, AL Laslett, et al. (2006). CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Nat Biotechnol 24:351-357.
13. Amps K, PW Andrews, G Anyfantis, L Armstrong, S Avery, H Baharvand, J Baker, D Baker, MB Munoz, et al. (2011). Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol 29:1132-1144.
14. Caisander G, H Park, K Frej, J Lindqvist, C Bergh, K Lundin and C Hanson. (2006). Chromosomal integrity maintained in five human embryonic stem cell lines after prolonged in vitro culture. Chromosome Res 14:131-137.
15. Inzunza J, S Sahlen, K Holmberg, AM Stromberg, H Teerijoki, E Blennow, O Hovatta and H Malmgren. (2004). Comparative genomic hybridization and karyotyping of human embryonic stem cells reveals the occurrence of an isodicentric X chromosome after long-term cultivation. Mol Hum Reprod 10:461-466.
16. Damjanov I and PW Andrews. (2007). The terminology of teratocarcinomas and teratomas. Nat Biotechnol 25:1212; discussion 1212.
17. Lensch MW and TA Ince. (2007). The terminology of teratocarcinomas and teratomas. Nat Biotechnol 25:1211; author reply 1211-1212.
18. Catalina P, C Bueno, R Montes, A Nieto, G Ligero, L Sanchez, M Jara, A Rasillo, A Orfao, et al. (2009). Genetic stability of human embryonic stem cells: a first-step toward the development of potential hESC-based systems for modeling childhood leukemia. Leuk Res 33:980-990.
19. Lavon N, K Narwani, T Golan-Lev, N Buehler, D Hill and N Benvenisty. (2008). Derivation of euploid human embryonic stem cells from aneuploid embryos. Stem Cells 26:1874-1882.
20. Blum B and N Benvenisty. (2007). Clonal analysis of human embryonic stem cell differentiation into teratomas. Stem Cells 25:1924-1930.
21. Blum B and N Benvenisty. (2009). The tumorigenicity of diploid and aneuploid human pluripotent stem cells. Cell Cycle 8:3822-3830.
22. Feki A, O Hovatta and M Jaconi. (2008). Derivation of human embryonic stem cell lines from single cells of 4-cell stage embryos: be aware of the risks. Hum Reprod 23:2874.
23. Hovatta O, M Jaconi, V Tohonen, F Bena, S Gimelli, A Bosman, F Holm, S Wyder, EM Zdobnov, et al. (2010). A teratocarcinoma-like human embryonic stem cell (hESC) line and four hESC lines reveal potentially oncogenic genomic changes. PLoS One 5:e10263.
24. Narva E, R Autio, N Rahkonen, L Kong, N Harrison, D Kitsberg, L Borghese, J Itskovitz-Eldor, O Rasool, et al. (2010). High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol 28:371-377.
25. Strom S, J Inzunza, KH Grinnemo, K Holmberg, E Matilainen, AM Stromberg, E Blennow and O Hovatta. (2007). Mechanical isolation of the inner cell mass is effective in derivation of new human embryonic stem cell lines. Hum Reprod 22:3051-3058.
26. Strom S, F Holm, R Bergstrom, AM Stromberg and O Hovatta. (2010). Derivation of 30 human embryonic stem cell lines -improving the quality. In Vitro Cell Dev Biol Anim 46:337-344.
27. Inzunza J, K Gertow, MA Stromberg, E Matilainen, E Blennow, H Skottman, S Wolbank, L Ahrlund-Richter and O Hovatta. (2005). Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells. Stem Cells 23:544-549.
28. Skottman H, S Narkilahti and O Hovatta. (2007). Challenges and approaches to the culture of pluripotent human embryonic stem cells. Regen Med 2:265-273.
29. Tang C, AS Lee, JP Volkmer, D Sahoo, D Nag, AR Mosley, MA Inlay, R Ardehali, SL Chavez, et al. (2011). An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Nat Biotechnol 29:829-834.